Health, Fitness, and Quality of Life in Adolescent Girls With Turner Syndrome

Sponsor
University of Colorado, Denver (Other)
Overall Status
Completed
CT.gov ID
NCT03181230
Collaborator
(none)
21
1
19.2
1.1

Study Details

Study Description

Brief Summary

This study plans to learn more about how the energy system works in girls with Turner syndrome. This is important to know so that the investigators understand how Turner syndrome relates to diseases such as diabetes, extra weight gain, heart disease and liver disease, and how this impacts day to day life.

Study Design

Study Type:
Observational
Actual Enrollment :
21 participants
Observational Model:
Case-Only
Time Perspective:
Cross-Sectional
Official Title:
Pilot Study of Health, Fitness, and Quality of Life in Adolescent Girls With Turner Syndrome
Actual Study Start Date :
May 26, 2017
Actual Primary Completion Date :
Dec 31, 2018
Actual Study Completion Date :
Dec 31, 2018

Arms and Interventions

Arm Intervention/Treatment
Adolescents

Adolescents and young adults with Turner syndrome will undergo studies of cardiometabolism, fitness, quality of life questionnaires, and a brief interview.

Other: No intervention
No intervention

Parents

One parent of a participant will complete parent-report quality of life questionnaires and a brief interview.

Other: No intervention
No intervention

Outcome Measures

Primary Outcome Measures

  1. Peak oxygen consumption [Baseline]

    Peak oxygen consumption (VO2 peak) with a standard graded exercise (bicycle) test

Secondary Outcome Measures

  1. Quality of Life Survey [Baseline]

    Self and parent reported quality of life

  2. Percent body fat [Baseline]

    Body composition by dual-energy x-ray absorptiometry

  3. Insulin resistance (IR) [Baseline]

    Fasting insulin and glucose used to calculate homeostatic model assessment (HOMA)

Other Outcome Measures

  1. Qualitative structured interview [Baseline]

    Attitudes surrounding physical activity participation

Eligibility Criteria

Criteria

Ages Eligible for Study:
12 Years to 21 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Female

  • Age 12-21 years

  • 45,XO karyotype in >50% of cells tested with a diagnosis of Turner syndrome (TS)

  • Tanner stage 2-5 for breast development

Exclusion Criteria:
  • Growth hormone treatment within the past 3 months

  • Diagnosis of type 1 or type 2 diabetes

  • Untreated hypertension with blood pressure > 99%ile for sex, age and height or >140/90

  • Weight > 300 lbs

  • Height < 54"

  • Aortic sinus of Valsalva or ascending aorta z-score > 2

  • Other cognitive, psychiatric, or physical impairment resulting in inability to tolerate the study procedures, including vigorous exercise

  • Pregnancy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Children's Hospital Colorado Aurora Colorado United States 80045

Sponsors and Collaborators

  • University of Colorado, Denver

Investigators

  • Principal Investigator: Shanlee Davis, MD, MS, University of Colroado

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Colorado, Denver
ClinicalTrials.gov Identifier:
NCT03181230
Other Study ID Numbers:
  • 17-0142
  • UL1TR001082
First Posted:
Jun 8, 2017
Last Update Posted:
May 3, 2021
Last Verified:
Apr 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Colorado, Denver
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 3, 2021